Anove LogoAnove LogoExplAIn
MapsAI frontrunners
Back to Directory

Transpara

by ScreenPoint Medical

AI Application
Low Confidence

Transpara is software for 2D mammograms and 3D digital breast tomosynthesis, used by breast radiologists in screening and diagnostic breast imaging. The vendor says the AI marks suspicious regions with a region risk score on a 98-point scale and puts each exam in an Elevated, Intermediate or Low risk category; Low risk exams are left unmarked. Further modules assess breast density and compare findings with up to three prior mammograms. The vendor says Transpara can be used as decision support while reading, as an independent second reader, or to organise the workflow, and that where double reading is practised users may use it as a partial replacement of the second reader or as a third reader. In each set-up the vendor describes, a radiologist still reads the exam. The vendor names PACS and AI-platform partners, but its website says nothing about where images are processed or hosted.

Visit Website

Transparency Score

Weighted across four pillars · updated October 20, 2026

Overall grade
40% weighted
ABCDF
Model
—
Not yet assessed
Infrastructure
—
Not yet assessed

Capabilities

Breast Cancer Detection
Exam Risk Categorisation
Lesion Marking
Breast Density Assessment
Prior Comparison

Vendor Information

Complete information about the vendor/provider of this AI application

ScreenPoint MedicalView all products →
ScreenPoint Medical B.V.(Trading as: ScreenPoint Medical)
Contact Information
screenpoint-medical.com
info@screenpointmed.com
+31 242 020 020
Registered Address
Toernooiveld 300, Nijmegen, Gelderland, 6525 EC, NL

EU AI Act Provider Information

Verification Status:
Unverified
(Last verified: October 20, 2026)
ScreenPoint Medical B.V.(Trading as: ScreenPoint Medical)
Toernooiveld 300, Nijmegen, Gelderland, 6525 EC, NL
info@screenpointmed.com+31 242 020 020
Compliance Documents
CE Marking: Certified
Notified Body: DEKRA Certification B.V.
ScreenPoint says 'Not all features are available in all countries' and describes CE-marked use as decision support, an independent second reader or a workflow tool, including as a (partial) replacement of the second reader or as a third reader where double reading is practised (https://screenpoint-medical.com/insights/transpara-regulatory-clearances, dated 22 Oct 2025, read 2026-10-20). Its website publishes no contraindications or instructions for use.
Compliance & Risk

Get insights into risk by running assessments on this AI application.

Work at ScreenPoint Medical? Claim this listing to correct or complete the data.

Added: October 20, 2026
Updated: October 20, 2026

Ready to manage AI applications?

Track, assess, and govern your AI applications with Anove.

Anove LogoAnove LogoAnove International B.V.

Helping organizations discover and manage AI applications responsibly. Your trusted source for AI governance and compliance.

Quick Links

  • Browse Directory
  • FAQ
  • AI maps by industry
  • Sign In

Resources

  • Documentation
  • Status
  • Anove.ai

Terms

  • Privacy Policy
  • Terms & Conditions
  • Responsible Disclosure
  • AI Legal Notice
  • Security Policy

© 2026 Anove International B.V. All rights reserved.